ADA Scientific Sessions 2025 Abstract
Sodium–Glucose Cotransporter 2 Inhibitor Combined with Low-Carbohydrate Diets Safely Achieves Moderate Ketosis in Healthy Volunteers—An Open-Label Pilot Study
Trial in peopleInterventions
Papers by Kellen L. Olszewski
1 result